Cited by 290Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease PrognosisAtherosclerosis and Cardiovascular Diseases

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit

Ridker, Paul M·2004·American Heart Journal

Abstract

Advances in vascular biology have shown that inflammation plays an integral role in the development of cardiovascular disease. Extensive study of high-sensitivity C-reactive protein (hs-CRP) has demonstrated that this measure of inflammation predicts cardiovascular risk not reflected by traditional risk factors, adds prognostic information to traditional risk assessment, and predicts long-term cardiovascular risk in individuals with no prior evidence of cardiovascular disease. Patients with elevated hs-CRP levels in the absence of elevated cholesterol appear to derive preventive benefit from statin therapy that is similar in magnitude to that in patients with elevated cholesterol. The large-scale Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosvastatin (JUPITER) trial represents a critical study to determine the utility of a strategy for targeting statin therapy to prevent incident cardiovascular disease in patients at increased cardiovascular risk on the basis of elevated hs-CRP who would not be considered candidates for therapy on the basis of hypercholesterolemia or traditional risk assessment. Inclusion of hs-CRP measurement in risk screening and use of this information to guide preventive therapy could result in a marked improvement in prevention of cardiovascular morbidity and mortality.

Integrity signals

Registry

Crossref · 10.1016/j.ahj.2004.04.028

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APOE genotyping was performed with allele-specific PCR with universal molecular beacons, and DNA sequencing of positive control DNA samples was completed to assure correct assignment of alleles.

    “Genotyping of APOE polymorphisms rs7412 and rs429358 was performed at PreventionGenetics (www.preventiongenetics.com) with an array tape [58] using allele-specific PCR with universal molecular beacons [59, 60]. DNA sequencing of positive control DNA samples were completed to assure correct assignment of alleles.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ridker, P. M.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Ridker, Paul M
Venue
American Heart Journal
Publisher
Elsevier BV
Published
2004-07
Volume
148
Issue
1
Pages
S19-S26
ISSN
0002-8703 (ISSN-L)
OpenAlex
W2084102521
Cited by
290
References
21
Citations by year
2026: 5 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 3 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 10 · 2016: 13 · 2015: 12 · 2014: 16 · 2013: 19 · 2012: 15
FWCI
26.53
Type
journal article
Language
en
Open access
closed
Locations
  • American Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
high-sensitivity C-reactive protein, inflammation, cardiovascular risk, cardiovascular disease prevention, statin therapy, rosuvastatin, JUPITER trial, primary prevention, cardiovascular risk assessment, hypercholesterolemia, risk screening
MeSH terms
Anticholesteremic Agents, C-Reactive Protein, Cardiovascular Diseases, Clinical Trials as Topic, Humans, Inflammation, Lipids, Cholesterol, LDL, Myocardial Infarction, Risk, Risk Factors, Stroke, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review